A topical therapeutic formulation engineered to eliminate dandruff and seborrheic dermatitis without causing adverse effects. Not a shampoo solution, but a "leave in" treatment. Approved under FDA monograph.

Categories: , ,
  1. General Details

    DandrOheal® is a topical solution designed to combat dandruff and seborrheic dermatitis. Unlike many treatments, DandrOheal® causes no irritation or unwanted side effects. It offers a side-effect-free option, ensuring a comfortable and safe experience for users.

    • Effective Formulation
      DandrOheal® eradicates dandruff and seborrheic dermatitis effectively within weeks. This rapid action alleviates discomfort and embarrassment associated with these conditions. It provides users with noticeable relief and improved scalp health. Users experience minimal recurrence, enjoying long-lasting results. The easy application and swift action make it an attractive choice. People seeking fast and reliable relief benefit from its effectiveness.
    • Dermatological Impact
      It provides a comprehensive solution for dandruff and seborrheic dermatitis. Patients no longer need multiple products or treatments. This singular solution simplifies the treatment process. It makes it more convenient and cost-effective for users.

    If you are interested in DandrOheal®, please visit this link.

  2. Patent Portfolio
    • U.S. Patent Pub. No. 20230390169 – Topical composition for treating dandruff and seborrheic dermatitis of a scalp
    • U.S. Patent App. No. 17/744,701 – Effective treatment for dandruff, a composition for treating dandruff and a method for making same
    • U.S. Patent App. No. 63/189,444 – Method of making a composition for treating dandruff
    • U.S. Patent App. No. 63/189,454 – Composition for treating dandruff
    • DandrOheal® Design Mark – Reg. No. 5,601,589
    • DandrOheal® Word Mark – Reg. No. 5,607,378

     

  3. Data Room Access & Additional Details

    Other Publicly Data Room Materials Available at VIP-3307 Public Data Room for Essential Remedium IP:

    • Other Introductory Materials
    • Patents, Trademarks, and Applications
    • Patent, Trademark, and Application File Histories
    • Product Pitch Decks
    • Videos
    • Non-Disclosure Agreement Draft to access more files listed below

    Additional Materials (available upon signing a mutual non-disclosure agreement):

    • Due Diligence Review
    • Assignments and Ownership
    • Valuations
    • Presentations
    • Clinical Reports
    • Earlier Business Plan
    • Regulatory Pathway
    • Additional Documents
  4. More Information

    Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Spencer Rogers at Vibrant IP, LLC at spencer@vibrantip.com and 415-997-9772.